Product Description
Product Name: Erlotinib Tablets
Form: Oral Tablet
Category: Targeted Therapy / EGFR Tyrosine Kinase Inhibitor
Indication: Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer, and Other EGFR-Positive Tumors
Erlotinib is a targeted anticancer medication classified as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. It is used in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and, in combination with gemcitabine, for advanced pancreatic cancer. It may also be considered in the management of other EGFR-overexpressing malignancies as determined by a healthcare provider.
